Clark Wesley
SEC insider (Form 3/4/5 filer). CIK 0001349193. Director at ImmunityBio, Inc. (IBRX) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in SAN DIEGO, CA.
Companies Clark Wesley has filed insider reports for
- ImmunityBio, Inc. (IBRX): Director
- Blue Acquisition Corp/Cayman (BACC): Director
Clark Wesley
CIK: 0001349193
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
